Tech Company Financing Transactions

Medcura Funding Round

Medcura secured a $22.4 million funding round on 4/3/2024. Investors included private investors.

Transaction Overview

Company Name
Announced On
4/3/2024
Transaction Type
Debt
Amount
$22,400,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its lead surgical product, the LifeGel� Absorbable Hemostatic Gel.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5650 Rivertech Ct. S
Riverdale, MD 20737
USA
Email Address
Overview
Medcura offers barriers that keep blood where it is supposed to be-in the patient-and keep bugs, dirt and other pathogens out. Our products rapidly stop bleeding independent of the body's clotting cascade, and work on wounds of all shapes and sizes. Using safe and naturally abundant biomaterials, our FDA-cleared products treat bleeding from the battlefield to the backyard.
Profile
Medcura LinkedIn Company Profile
Social Media
Medcura Company Twitter Account
Company News
Medcura News
Facebook
Medcura on Facebook
YouTube
Medcura on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Larry Tiffany
  Larry Tiffany LinkedIn Profile  Larry Tiffany Twitter Account  Larry Tiffany News  Larry Tiffany on Facebook
Chief Financial Officer
Richard Vincent
  Richard Vincent LinkedIn Profile  Richard Vincent Twitter Account  Richard Vincent News  Richard Vincent on Facebook
Chief Scientific Officer
Matthew Dowling
  Matthew Dowling LinkedIn Profile  Matthew Dowling Twitter Account  Matthew Dowling News  Matthew Dowling on Facebook
VP - Bus. Development
Steve Ford
  Steve Ford LinkedIn Profile  Steve Ford Twitter Account  Steve Ford News  Steve Ford on Facebook
VP - Manufacturing
Bruce Choi
  Bruce Choi LinkedIn Profile  Bruce Choi Twitter Account  Bruce Choi News  Bruce Choi on Facebook
VP - Product Management
Colleen Nye
  Colleen Nye LinkedIn Profile  Colleen Nye Twitter Account  Colleen Nye News  Colleen Nye on Facebook
VP - Regulatory Affairs
Elsa Abruzzo
  Elsa Abruzzo LinkedIn Profile  Elsa Abruzzo Twitter Account  Elsa Abruzzo News  Elsa Abruzzo on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/3/2024: dappOS venture capital transaction
Next: 4/3/2024: MIACH Orthopaedics venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary